Overview
Axion BioSystems develops live-cell analysis tools including multielectrode array (MEA) platforms, bioelectronic assays, and high-throughput imaging systems like Omni Pro 12 for real-time cell function monitoring. These technologies support drug discovery, disease research, and cell/gene therapy development without animal testing, used in biopharma and academia for applications in neurology, oncology, and neuroimmunology. Products enable noninvasive electrical/optical stimulation, AI-driven imaging, and automated cell counting.
Frequently asked questions
- What live-cell analysis platforms does Axion BioSystems offer?
- Axion offers Maestro MEA platforms for electrical activity recording, Omni live-cell imaging systems with AI analysis for brightfield/fluorescence, and tools for optical/electrical stimulation in neural networks.
- What applications are supported by Axion's products?
- Products support drug discovery in neurology, oncology, neuroimmunology, cell/gene therapies, and real-time monitoring of cellular growth, death, excitability, and network connectivity.
- Are Axion BioSystems products suitable for high-throughput workflows?
- Yes, the Omni Pro 12 provides high-throughput live-cell imaging with integrated robotics, multiplate incubator compatibility, and automated imaging for enhanced efficiency in experiments.